Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Additional Information (Details)

v3.21.2
Stockholders' Equity - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Oct. 05, 2020
Common Stock, Shares Authorized 13,000,000 13,000,000 500,000,000
Preferred Stock, Shares Authorized 5,000,000 5,000,000 10,000,000
Issued shares in lieu of certain liabilities 262,125    
Board of directors fees $ 0.7    
Common stock issued for consideration consisting of deferred salary and bonus liabilities 135,560    
Deferred salary and bonus liabilities $ 0.3    
Convertible notes payable [Member]      
Number of Shares Converted 181,463    
Conversion of Stock, Amount Issued $ 1.7